ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,045Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 133

$693K Total Retail Price of All Prescriptions

Rank: 2 out of 133

875 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,495 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
CLOPIDOGREL 881 804 1 9
PLAVIX 689 634 2 12
BISOPROLOL-HYDROCHLOROTHIAZIDE 406 337 3 55
ISOSORBIDE MONONITRATE ER 398 309 4 11
AMLODIPINE BESYLATE 392 351 5 4
SIMVASTATIN 383 319 6 3
EFFIENT 321 224 7 38
POTASSIUM CHLORIDE 298 261 8 14
FUROSEMIDE 260 213 9 6
CARVEDILOL 205 141 10 1
WARFARIN SODIUM 179 170 11 8
DIGOXIN 172 123 12 13
ATORVASTATIN CALCIUM 171 131 13 10
NITROSTAT 169 121 14 22
BYSTOLIC 156 132 15 30
ATENOLOL 153 122 16 16
LISINOPRIL 151 120 17 2
LOSARTAN POTASSIUM 148 136 18 15
LOVASTATIN 142 130 19 54
PANTOPRAZOLE SODIUM 134 104 20 33
METOPROLOL TARTRATE 126 101 21 5
AMIODARONE HCL 125 117 22 23
TEKTURNA 122 104 23 78
ZETIA 110 79 24 29
FAMOTIDINE 107 96 25 58
NIASPAN 104 90 26 27
LOSARTAN-HYDROCHLOROTHIAZIDE 102 85 27 37
TEKTURNA HCT 96 87 10 28 83
DILTIAZEM HCL 91 91 29 84
BISOPROLOL FUMARATE 90 78 30 56
SPIRONOLACTONE 84 48 31 21
CILOSTAZOL 83 76 32 51
CRESTOR 83 83 32 19
DIOVAN 79 59 34 44
TRIAMTERENE-HCTZ 77 77 35 60
OMEPRAZOLE 77 51 35 41
BUMETANIDE 69 59 37 31
PRAVASTATIN SODIUM 67 67 38 18
METOPROLOL SUCCINATE 67 51 38 7
RANEXA 64 41 40 60
DIOVAN HCT 63 63 41 80
KLOR-CON M20 63 47 41 28
LEVOTHYROXINE SODIUM 62 60 43 43
GEMFIBROZIL 61 45 44 65
HYDROCHLOROTHIAZIDE 61 54 44 20
FLECAINIDE ACETATE 59 59 46 26
VERAPAMIL ER 56 52 47 48
CLONIDINE HCL 53 53 48 42
SOTALOL 52 49 49 17
VYTORIN 52 32 49 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.